Brief: Entero Therapeutics Receives Non-Compliance Notice From Nasdaq
23/08/2024 23:24
Aug 23 (Reuters) - Entero Therapeutics Inc ENTO.O :
* ENTERO THERAPEUTICS INC SAYS RECEIVES NON-COMPLIANCE
NOTICE FROM
NASDAQ
Source text for Eikon: ID:nGNX54L63R
Further company coverage: ENTO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on GridAI Technologies
See all newsBrief: Gridai Technologies Corp - Enters $2.54 Million Private Placement Of Shares And Warrants - SEC Filing
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement